Abstract
Hepatocellular carcinoma (HCC) is a malignant tumor unresponsive to most current therapies. Small peptides, either synthetic or derived from natural proteins, are found promising in treating HCC. Herein, different types of small peptides and their associated mechanistic actions against tumors are discussed, postulating their use as alternative treatments for HCC.
Keywords: Protein peptide, liver cancer, diagnosis, therapy, hepatocellular carcinoma
Protein & Peptide Letters
Title: The Use of Small Peptides in the Diagnosis and Treatment of Hepatocellular Carcinoma
Volume: 16 Issue: 5
Author(s): Felice H. Tsang, Nikki P. Lee and John M. Luk
Affiliation:
Keywords: Protein peptide, liver cancer, diagnosis, therapy, hepatocellular carcinoma
Abstract: Hepatocellular carcinoma (HCC) is a malignant tumor unresponsive to most current therapies. Small peptides, either synthetic or derived from natural proteins, are found promising in treating HCC. Herein, different types of small peptides and their associated mechanistic actions against tumors are discussed, postulating their use as alternative treatments for HCC.
Export Options
About this article
Cite this article as:
Tsang H. Felice, Lee P. Nikki and Luk M. John, The Use of Small Peptides in the Diagnosis and Treatment of Hepatocellular Carcinoma, Protein & Peptide Letters 2009; 16 (5) . https://dx.doi.org/10.2174/092986609788167860
DOI https://dx.doi.org/10.2174/092986609788167860 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Cytotoxic Effects on B Lymphocytes Mediated by Reactive Oxygen Species
Current Pharmaceutical Design CDK9: Therapeutic Perspective in HCC Therapy
Current Cancer Drug Targets Cyclin-Dependent Kinase 4/6 (Cdk4/6) Inhibitors: Perspectives in Cancer Therapy and Imaging
Mini-Reviews in Medicinal Chemistry Molecular Bases of Liver Cancer Refractoriness to Pharmacological Treatment
Current Medicinal Chemistry RNAi in Clinical Studies
Current Medicinal Chemistry Generation of Targeted Adeno-Associated Virus (AAV) Vectors for Human Gene Therapy
Current Pharmaceutical Design Breath Analysis Using SIFT-MS to Assess Metabolic Status in Patients After Gastro-oesophageal Cancer Surgery- a Pilot Study
Current Analytical Chemistry Editorial (Thematic Issue: Targeting Anti-Cancer Agents and Cancer Treatments)
Anti-Cancer Agents in Medicinal Chemistry Immunomodulatory Activity of Astragalus, Ginseng and Echinacea: From Keith Block and Mark Mead to Today, Have We Moved On?
Current Immunology Reviews (Discontinued) Nanoliposome is a Promising Carrier of Protein and Peptide Biomolecule for the Treatment of Cancer
Anti-Cancer Agents in Medicinal Chemistry Cell-in-cell phenomenon: A New Paradigm in Life Sciences.
Current Molecular Medicine MicroRNAs Contribute to Hepatocellular Carcinoma
Mini-Reviews in Medicinal Chemistry Monoclonal Antibodies in Cancer Therapy
Current Medicinal Chemistry - Anti-Cancer Agents Biomarker Identification for Liver Hepatocellular Carcinoma and Cholangiocarcinoma Based on Gene Regulatory Network Analysis
Current Bioinformatics Immunotherapy Resistance Mechanisms in Renal Cell Cancer
Current Signal Transduction Therapy Cilostazol as a Unique Antithrombotic Agent
Current Pharmaceutical Design Low Molecular Weight and Oligomeric Chitosans and Their Bioactivities
Current Topics in Medicinal Chemistry p53-Induced Apoptosis and Inhibitors of p53
Current Medicinal Chemistry Editorial (Hot Topic: Novel Aspects of Apoptosis Modulating Drugs)
Current Pharmaceutical Biotechnology MicroRNA Targeting as a Therapeutic Strategy Against Glioma
Current Molecular Medicine